why choose us

Clinical Trials Search

Showing 17,530 of 132,963 result(s)
Adaptive Trial Scheduling in Naming Treatment for Aphasia

Status: Completed

Condition: Aphasia

Interventions: Each of the 200 target words for practice are presented on a schedule determined by an algorithm that relies on the pattern of correct vs. incorrect r

Date: 2022-12-07

Metabolically Fit CD19 CAR T-cell Therapy With CD34 Selection in Patients With CD19+ Relapsed;Refractory NHL, CLL;SLL

Status: Completed

Condition: B-cell Non Hodgkin Lymphoma

Interventions: 500 mg;m2 IV over 30-60 minutes +;- 10 minutes before Fludarabine Days -5, -4, - 3

Date: 2022-12-07

Novel Combinations in Participants With Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma

Status: Completed

Condition: Gastric Cancer

Interventions: an anti PD-1 and anti-TIGIT bispecific antibody; IV infusion

Date: 2022-12-07

Propranolol in Combination With Pembrolizumab and Standard Chemotherapy for the Treatment of Unresectable Locally Advanced or Metastatic Esophageal or Gastroesophageal Junction Adenocarcinoma

Status: Completed

Condition: Clinical Stage II Esophageal Adenocarcinoma AJCC v8

Interventions: Undergo tissue collection

Date: 2022-12-07

Preventing Childbirth-Related PTSD With Expressive Writing

Status: Completed

Condition: PTSD (Childbirth-Related)

Interventions: Participants will write repeatedly about their deepest emotions and thoughts related to their recent childbirth, focusing on the most stressful experi

Date: 2022-12-07

Noninvasive Ultrasound Assessment of Detrusor Dysfunction

Status: Completed

Condition: Bladder Dysfunction

Interventions:

Date: 2022-12-07

Artificial Pancreas Technology to Reduce Glycemic Variability and Improve Cardiovascular Health in Type 1 Diabetes

Status: Completed

Condition: Type 1 Diabetes

Interventions: FDA approved Tandem t:slim insulin pump with Control-IQ Technology and the Dexcom G6 CGM

Date: 2022-12-07

PerQseal® Clinical Study

Status: Completed

Condition: Percutaneous Large Hole Vascular Closure

Interventions: Bioabsorbable implant delivered percutaneously to achieve haemostasis of common femoral arteriotomies created by 12 to 22 F sheaths (up to 26 F arteri

Date: 2022-12-07

REsynchronization Comparison In LBBB and Normal or Mildly Reduced VENTricular Function With CRT (REINVENT-CRT)

Status: Completed

Condition: Left Ventricular Ejection Fraction

Interventions: LB-CRT (DDD 60-130, LV lead turned off) (active intervention #1)

Date: 2022-12-07

Reducing the Incidence of Symptomatic Brain Metastases With MRI Surveillance

Status: Completed

Condition: Brain Metastases

Interventions: An MRI brain scan with and without gadolinium contrast.
Three scans are planned for each participant.

Date: 2022-12-07